Comparing estimates of cost effectiveness

Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study -- Miners et al. 330 (7482): 65 -- BMJ
BMJ 2005;330 (8 January), doi:10.1136/bmj.330.7482.0-d

Decision makers need to judge credibility of economic evaluations
Cost effectiveness assessments submitted to the technology appraisal programme of the National Institute for Clinical Excellence (NICE) by manufacturers of the relevant healthcare technologies differ significantly from those contracted by university based assessment groups. Miners and colleagues (p 65) retrospectively compared 62 appraisals. Manufacturers' estimates of incremental cost effectiveness ratios were lower (suggesting a more cost effective use of resources) than those produced by the assessment groups (25 were lower, 29 were the same, none were higher; P < 0.01).